Abstract:Microvessel density (MVD) is regarded as a surrogate marker for angiogenesis and has been used for tumor prognosis. In this study, MVD was identified immunohistochemically by monoclonal antibodies against CD105 and CD34 in the tissues representing gastric carcinoma, chronic gastritis, and hyperplastic polyps, and the results were correlated with clinicopathologic features. The expression of CD105 in the microvessels within benign lesions was barely visible, and MVD was markedly lower than that determined by CD34. CD34 was strongly expressed in the microvessels within hyperplastic polyps and tissues with gastritis. In gastric carcinoma, CD105 expression in microvessels was as high as the MVD, compared with benign lesions. CD105 stained well-formed mature and newly formed immature vessels within the cancer mass. Correlation analysis showed that MVD determined by CD105 correlated with blood vessel invasion, distant metastasis, and formation of ascites. Survival analysis demonstrated an inverse correlation between MVD count and overall survival: patients with MVD counts of 32 or higher survived for a much shorter time than those with counts lower than 32. Multivariate analysis confirmed that MVD determined by CD105 was an independent prognostic factor for survival. Microvessel density determined by CD34 inversely correlated with overall survival, but it did not correlate with other clinicopathologic parameters except formation of ascites. In conclusion, CD34 was universally expressed in blood vessels within benign and malignant tissues, whereas CD105 expression was minimal in benign tissues but stronger in gastric carcinoma. These data suggest that both CD105 and CD34 could be used for quantification of angiogenesis, but preference should be given to CD105 in the evaluation of prognosis in gastric carcinoma.

Microvessel Density and Cell Proliferative Index in Cardiac Adenocarcinoma

Prognostic Significance of Microlymphatic Vessel Density and Microvascular Density in Colorectal Carcinoma

Expression and Significance of PCNA Protein and MVD in Pancreatic Adenocarcinoma

Relationship Between Enhanced Intensity and Microvessel Density of Gastric Carcinoma Using Double Contrast-enhanced Ultrasonography:Preliminary Study

The Relationship Between the Microvessel Density and Clinical Pathologic Status in Patients with Esophageal Carcinoma

Prognostic Significance of Microvessel Density in Intrahepatic Cholangiocarcinoma

[Expression of Microvessel Density in Multistep Tissues of Gastric Carcinoma and Significance Thereof].

Expression and prognostic significance of Ki-67 and microvessel density in gastric adenocarcinoma

[Study on the Relationship Between Microvascular Density and Prognosis in Laryngeal Cancer].

[Gastrointestinal Adenocarcinomas with a Micropapillary Pattern: a Clinicopathologic and Immunohistochemical Study].

Quantification of Microvascular Dentsity and Cell Nuclear DNA Content in Laryngeal Cancer

Expression and prognostic significance of PTEN and microvessel density in gastric adenocarcinoma

Study on the Expression of Miscrovessel Count and P53 Protein in Human Lung Adenocarcinoma

Microvessel density and Ki67 expression and their clinical significance in colorectal adenocarcinoma

Relationship of adrenomedullin expression with microvessel density and prognosis in carcinoma of endometrium

Study of Microvessel Density and Vascular Endothelial Growth Factor in Non-small Cell Lung Cancer

The Detection of Microvessel Density in Non-Small-cell Lung Carcinoma (NSCLC) and Its Clinical Significance

Relationship Between Dynamic Contrast-Enhanced MRI Parameters and Angiogenesis in Peripheral Pulmonary Adenocarcinoma

The Relationship Between Lymphatic Microvessel Density and Clinical Pathology of Gastric Carcinoma

Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.

Counts of Tumor-associated Macrophage,Microvessel and Lymph Vessel in Benign and Malignant Lesions of Gallbladder